| Literature DB >> 18415712 |
Lívia Kipikasová1, Tomás Wolaschka, Peter Bohus, Helena Baumohlová, Juraj Bober, Jana Blazejová, Ladislav Mirossay, Marek Sarisský, Andrej Mirossay, Martina Cizmáriková, Dana Potoceková, Ján Mojzis.
Abstract
The purpose of this case control study was to evaluate the role of X-ray repair cross-complementing group 1 (XRCC1) and xeroderma pigmentosum group D (XPD) genotypes as genetic indicators of susceptibility to breast cancer (BC). We analysed DNA samples from 114 breast cancer patients and 113 control subjects using polymerase chain reaction-restriction fragment length polymorphism. For the single nucleotide polymorphisms in XRCC1 exon 10 (Arg399Gln, G/A) and XPD exon 23 (Lys751Gln, A/C), no remarkable differences for genotype distribution and allele frequencies were observed between BC group and control group in the study. The genotype frequency for homozygote A/A in XPD exon 6 (Arg156Arg, C/A) were significantly different between BC and control groups (P < 0.0001, odds ratio = 2.14; 95% confidence interval 1.44-3.17). The data indicate a possible role for XPD (Arg156Arg, C/A) polymorphisms in BC susceptibility.Entities:
Mesh：
Substances：
Year: 2008 PMID： 18415712 DOI： 10.1007/s12253-008-9034-z
Source DB: PubMed Journal: Pathol Oncol Res ISSN： 1219-4956 Impact factor: 3.201